Literature DB >> 30928277

Ursolic acid: An overview on its cytotoxic activities against breast and colorectal cancer cells.

Eric Wei Chiang Chan1, Chu Yong Soon2, Joash Ban Lee Tan3, Siu Kuin Wong3, Yew Woh Hui4.   

Abstract

Ursolic acid (UA) is a pentacyclic triterpene of the ursane type. As a common chemical constituent among species of the family Lamiaceae, UA possesses a broad spectrum of pharmacological properties. This overview focuses on the anticancer properties of UA against breast cancer (BC) and colorectal cancer (CRC) that are most common among women and men, respectively. In vitro studies have shown that UA inhibited the growth of BC and CRC cell lines through various molecular targets and signaling pathways. There are several in vivo studies on the cytotoxic activity of UA against BC and CRC. UA also inhibits the growth of other types of cancer. Studies on structural modifications of UA have shown that the -OH groups at C3 and at C28 are critical factors influencing the cytotoxic activity of UA and its derivatives. Some needs for future research are suggested. Sources of information were from ScienceDirect, Google Scholar and PubMed.
Copyright © 2019 Shanghai Changhai Hospital. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytotoxic; Molecular targets; Signaling pathways; Ursolic acid

Mesh:

Substances:

Year:  2019        PMID: 30928277     DOI: 10.1016/j.joim.2019.03.003

Source DB:  PubMed          Journal:  J Integr Med


  10 in total

1.  Ursolic Acid Enhances the Sensitivity of MCF-7 and MDA-MB-231 Cells to Epirubicin by Modulating the Autophagy Pathway.

Authors:  Zhennan Wang; Pingping Zhang; Huan Jiang; Bing Sun; Huaizhi Luo; Aiqun Jia
Journal:  Molecules       Date:  2022-05-25       Impact factor: 4.927

2.  Cytotoxic Effects of Some Nepeta Species against Breast Cancer Cell Lines and Their Associated Phytochemical Properties.

Authors:  Esra Köngül Şafak; Gökçe Şeker Karatoprak; Tuncay Dirmenci; Hayri Duman; Nurgün Küçükboyacı
Journal:  Plants (Basel)       Date:  2022-05-27

Review 3.  Harnessing the Power of Optical Microscopic and Macroscopic Imaging for Natural Products as Cancer Therapeutics.

Authors:  Tianyu Yan; Qi Zeng; Lin Wang; Nan Wang; Honghao Cao; Xinyi Xu; Xueli Chen
Journal:  Front Pharmacol       Date:  2019-11-28       Impact factor: 5.810

Review 4.  Ursolic Acid-Based Derivatives as Potential Anti-Cancer Agents: An Update.

Authors:  Vuyolwethu Khwaza; Opeoluwa O Oyedeji; Blessing A Aderibigbe
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

Review 5.  The Optimized Delivery of Triterpenes by Liposomal Nanoformulations: Overcoming the Challenges.

Authors:  Andreea Milan; Alexandra Mioc; Alexandra Prodea; Marius Mioc; Roxana Buzatu; Roxana Ghiulai; Roxana Racoviceanu; Florina Caruntu; Codruţa Şoica
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

6.  Investigating the Multitarget Pharmacological Mechanism of Ursolic Acid Acting on Colon Cancer: A Network Pharmacology Approach.

Authors:  Jun Zhao; Ping Leng; Wen Xu; Jia-Lin Sun; Bei-Bei Ni; Guang-Wei Liu
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-04       Impact factor: 2.629

Review 7.  Targeting the JAK/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy.

Authors:  Sankhadip Bose; Sabyasachi Banerjee; Arijit Mondal; Utsab Chakraborty; Joshua Pumarol; Courtney R Croley; Anupam Bishayee
Journal:  Cells       Date:  2020-06-11       Impact factor: 6.600

8.  Antioxidant and Antiproliferative Potential of Bioactive Molecules Ursolic Acid and Thujone Isolated from Memecylon edule and Elaeagnus indica and Their Inhibitory Effect on Topoisomerase II by Molecular Docking Approach.

Authors:  Ramalingam Srinivasan; Arumugam Aruna; Jong Suk Lee; Myunghee Kim; Muthugounder Subramaniam Shivakumar; Devarajan Natarajan
Journal:  Biomed Res Int       Date:  2020-02-14       Impact factor: 3.411

Review 9.  Research Progress of Carrier-Free Antitumor Nanoparticles Based on Phytochemicals.

Authors:  Siliang Jiang; Yu Fu; Xinyang Zhang; Tong Yu; Bowen Lu; Juan Du
Journal:  Front Bioeng Biotechnol       Date:  2021-12-08

10.  miR-641 Inhibited Cell Proliferation and Induced Apoptosis by Targeting NUCKS1/PI3K/AKT Signaling Pathway in Breast Cancer.

Authors:  Li Li; Da Wei; Junying Zhang; Rong Deng; Jinhai Tang; Dongming Su
Journal:  Comput Math Methods Med       Date:  2022-01-12       Impact factor: 2.238

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.